![Close up of Emgality injection, one of four recently approved migraine prevention medications. Illustrative editorial taken in Vista, CA USA on Januar Stock Photo - Alamy Close up of Emgality injection, one of four recently approved migraine prevention medications. Illustrative editorial taken in Vista, CA USA on Januar Stock Photo - Alamy](https://c8.alamy.com/comp/2E5XAP1/close-up-of-emgality-injection-one-of-four-recently-approved-migraine-prevention-medications-illustrative-editorial-taken-in-vista-ca-usa-on-januar-2E5XAP1.jpg)
Close up of Emgality injection, one of four recently approved migraine prevention medications. Illustrative editorial taken in Vista, CA USA on Januar Stock Photo - Alamy
![These highlights do not include all the information needed to use EMGALITY safely and effectively. See full prescribing information for EMGALITY. EMGALITY (galcanezumab-gnlm) injection, for subcutaneous useInitial U.S. Approval: 2018 These highlights do not include all the information needed to use EMGALITY safely and effectively. See full prescribing information for EMGALITY. EMGALITY (galcanezumab-gnlm) injection, for subcutaneous useInitial U.S. Approval: 2018](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=emgality-ifu-100mg-pfs-7-v1.jpg&id=603670)
These highlights do not include all the information needed to use EMGALITY safely and effectively. See full prescribing information for EMGALITY. EMGALITY (galcanezumab-gnlm) injection, for subcutaneous useInitial U.S. Approval: 2018
![Comparing prefilled syringe and autoinjector in galcanezumab studies – Video abstract [ID 170636] - YouTube Comparing prefilled syringe and autoinjector in galcanezumab studies – Video abstract [ID 170636] - YouTube](https://i.ytimg.com/vi/rJF9vreAX_A/mqdefault.jpg)